Pharmacovigilance Scientist – Patient Safety BioPharma

Pharmacovigilance Scientist – Patient Safety BioPharma

Arbetsbeskrivning

At AstraZeneca we’re dedicated to being a Great Place to Work. Where you are empowered to push the boundaries of science and unleash your entrepreneurial spirit. There’s no better place to make a difference to medicine, patients and society. An inclusive culture that champions diversity and collaboration. Always committed to lifelong learning, growth and development.
Patient Safety at AstraZeneca is now looking for Pharmacovigilance Scientists to join our Patient Safety BioPharma team. The positions will be based in Gothenburg, Sweden. We are offering opportunities at different levels (e.g. PV Scientist, Senior PV Scientist and Principal PV Scientist) depending on your expertise and previous experience.
The current positions are within the therapy areas of Cardiovascular, Renal & Metabolism and Respiratory & Immunology. The core purpose of AstraZeneca Patient Safety is to add value to AstraZeneca products, provide clear science-based guidance for investigators and prescribers to safeguard patients as well as the success of our business. Patient Safety covers the entire clinical life cycle of a drug from first time into man to withdrawal of a product from the market
What you’ll do
As a Pharmacovigilance Scientist, you work with Patient Safety Physicians and other PV Scientist(s) with review, analysis and interpretation of safety data obtained from patients who have been administered the assigned medicinal products in clinical development programs and/or from marketed use. You provide authoring and pharmacovigilance input to safety documents and regulatory reports and lead internal and external meetings to present safety data and analyses. You evaluate the clinical implications of safety data from pre-clinical studies, clinical studies, literature and other information sources to establish the safety profile of drugs and manage the risk to patients.
Essential for the role
We think you are looking for a position where you truly can make an impact and have the opportunity to collaborate across global boundaries. You have a life sciences/pharmacy/nursing degree with proven analytical skills and understanding of scientific methodology. You are curious and want to take the opportunity to learn, grow and develop from a wide range of experiences and have good attention to details. You have a flexible, team orientated attitude with solid leadership skills and you are fluent in written and spoken English. It is meriting if you have previous working experience from drug development and/or pharmacovigilance activities in a Pharmaceutical company, Academic research or Health Authority environment and if you have knowledge of pharmacovigilance regulations.
This is an exciting opportunity for professional growth in areas of drug development, science, and leadership. If you’re inspired by the possibilities of science to make a difference and ready to discover what you can do – join us.
Why AstraZeneca?
Our purpose is ambitious and so is our approach. Becoming a more agile and innovative company means building a dynamic, inspiring culture where we celebrate forward thinking and act with a sense of urgency. We are ambitious, take informed risks and learn from both success and failure. We are curious, creative and open to new ideas and ways of working. Above all, we are passionate about science and driven to always put patients first. Are you ready to move forward in your career?

Sammanfattning

  • Arbetsplats: AstraZeneca Göteborg MÖLNDAL
  • 1 plats
  • 6 månader eller längre
  • Heltid
  • Fast månads- vecko- eller timlön
  • Publicerat: 15 juli 2022
  • Ansök senast: 28 juli 2022

Besöksadress

PEPPAREDSLEDEN 1
MÖLNDAL

Postadress

None
MÖLNDAL, 43183

Liknande jobb


Bioinformatics Research Scientist

Bioinformatics Research Scientist

19 december 2024

18 december 2024

Postdoktor inom stamcellsbaserade modeller av schizofreni

Postdoktor inom stamcellsbaserade modeller av schizofreni

16 december 2024

13 december 2024